CDR Update - Issue 45

In This Issue

The following recommendations were issued through CADTH’s Common Drug Review program from October 1 to December 31, 2007.

Drug Name (Brand Name)	Indication (Condition)	Recommendation Released	Final CEDAC Recommendation (Click link to view full recommendation and reasons for recommendation)
ciprofloxacin hydrochloride & dexamethasone otic suspension (Ciprodex)	Ear infections	2007-10-18	List with criteria/condition
adefovir dipivoxil (Hepsera)	Hepatitis B	2007-10-18	List with criteria/condition
entecavir (Baraclude)	Chronic Hepatitis B	2007-11-28	List with criteria/condition
adalimumab (Humira)	Crohn's disease	2007-12-19	List with criteria/condition
idursulfase (Elaprase)	Mucopolysarccharidosis II (MPS II), Hunter Syndrome	2007-12-19	Do not list

The CDR Directorate is currently recruiting for:

• Manager of Drug Reviews

If you are interested in learning more about these career opportunities, visit Careers/Job Listings on the CADTH web site.